Logo image of RUN

SUNRUN INC (RUN) Stock Fundamental Analysis

NASDAQ:RUN - Nasdaq - US86771W1053 - Common Stock - Currency: USD

9.96  -0.38 (-3.68%)

After market: 10.08 +0.12 (+1.2%)

Fundamental Rating

2

We assign a fundamental rating of 2 out of 10 to RUN. RUN was compared to 93 industry peers in the Electrical Equipment industry. RUN may be in some trouble as it scores bad on both profitability and health. RUN is quite expensive at the moment. It does show a decent growth rate.


Dividend Valuation Growth Profitability Health

Quickly go to:

1

1. Profitability

1.1 Basic Checks

In the past year RUN was profitable.
RUN had a negative operating cash flow in the past year.
RUN had negative earnings in 4 of the past 5 years.
RUN had a negative operating cash flow in each of the past 5 years.
RUN Yearly Net Income VS EBIT VS OCF VS FCFRUN Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 -1B -2B -3B

1.2 Ratios

With a Return On Assets value of -13.29%, RUN perfoms like the industry average, outperforming 54.84% of the companies in the same industry.
RUN has a Return On Equity of -103.55%. This is in the lower half of the industry: RUN underperforms 61.29% of its industry peers.
Industry RankSector Rank
ROA -13.29%
ROE -103.55%
ROIC N/A
ROA(3y)-7.08%
ROA(5y)-4.59%
ROE(3y)-46.51%
ROE(5y)-28.73%
ROIC(3y)N/A
ROIC(5y)N/A
RUN Yearly ROA, ROE, ROICRUN Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 -20 -40 -60 -80 -100

1.3 Margins

RUN has a Gross Margin of 18.95%. This is comparable to the rest of the industry: RUN outperforms 46.24% of its industry peers.
RUN's Gross Margin has declined in the last couple of years.
RUN does not have Profit Margin and Operating Margin available, so we won't be analyzing them here.
Industry RankSector Rank
OM N/A
PM (TTM) N/A
GM 18.95%
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y2.02%
GM growth 5Y-8.23%
RUN Yearly Profit, Operating, Gross MarginsRUN Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 -50 -100

More info and screens

1

2. Health

2.1 Basic Checks

RUN does not have a ROIC to compare to the WACC, probably because it is not profitable.
Compared to 1 year ago, RUN has more shares outstanding
RUN has more shares outstanding than it did 5 years ago.
RUN has a worse debt/assets ratio than last year.
RUN Yearly Shares OutstandingRUN Yearly Shares OutstandingYearly Shares Outstanding 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 50M 100M 150M 200M
RUN Yearly Total Debt VS Total AssetsRUN Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 5B 10B 15B 20B

2.2 Solvency

Based on the Altman-Z score of -0.17, we must say that RUN is in the distress zone and has some risk of bankruptcy.
Looking at the Altman-Z score, with a value of -0.17, RUN is in line with its industry, outperforming 45.16% of the companies in the same industry.
A Debt/Equity ratio of 5.11 is on the high side and indicates that RUN has dependencies on debt financing.
RUN has a worse Debt to Equity ratio (5.11) than 79.57% of its industry peers.
Industry RankSector Rank
Debt/Equity 5.11
Debt/FCF N/A
Altman-Z -0.17
ROIC/WACCN/A
WACC4.76%
RUN Yearly LT Debt VS Equity VS FCFRUN Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 5B 10B

2.3 Liquidity

A Current Ratio of 1.32 indicates that RUN should not have too much problems paying its short term obligations.
RUN has a Current ratio of 1.32. This is in the lower half of the industry: RUN underperforms 62.37% of its industry peers.
A Quick Ratio of 0.99 indicates that RUN may have some problems paying its short term obligations.
With a Quick ratio value of 0.99, RUN perfoms like the industry average, outperforming 48.39% of the companies in the same industry.
Industry RankSector Rank
Current Ratio 1.32
Quick Ratio 0.99
RUN Yearly Current Assets VS Current LiabilitesRUN Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 500M 1B 1.5B 2B

More info and screens

6

3. Growth

3.1 Past

RUN shows a strong growth in Earnings Per Share. In the last year, the EPS has been growing by 126.84%, which is quite impressive.
Measured over the past years, RUN shows a very strong growth in Earnings Per Share. The EPS has been growing by 42.86% on average per year.
Looking at the last year, RUN shows a decrease in Revenue. The Revenue has decreased by -2.09% in the last year.
RUN shows quite a strong growth in Revenue. Measured over the last years, the Revenue has been growing by 18.87% yearly.
EPS 1Y (TTM)126.84%
EPS 3YN/A
EPS 5Y42.86%
EPS Q2Q%150%
Revenue 1Y (TTM)-2.09%
Revenue growth 3Y8.17%
Revenue growth 5Y18.87%
Sales Q2Q%10.06%

3.2 Future

The Earnings Per Share is expected to grow by 35.19% on average over the next years. This is a very strong growth
The Revenue is expected to grow by 9.27% on average over the next years. This is quite good.
EPS Next Y-147.71%
EPS Next 2Y-64.08%
EPS Next 3Y-39.98%
EPS Next 5Y35.19%
Revenue Next Year9.23%
Revenue Next 2Y10.07%
Revenue Next 3Y11.61%
Revenue Next 5Y9.27%

3.3 Evolution

The EPS growth rate is stable: in the next years the growth will be about the same than in the last years.
When comparing the Revenue growth rate of the last years to the growth rate of the upcoming years, we see that the growth is decreasing.
RUN Yearly Revenue VS EstimatesRUN Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 2029 2030 2031 1B 2B 3B 4B
RUN Yearly EPS VS EstimatesRUN Yearly EPS VS EstimatesYearly EPS VS Estimates 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 2029 2030 2031 0 2 -2 4 -4 -6

More info and screens

3

4. Valuation

4.1 Price/Earnings Ratio

The Price/Earnings ratio is 5.56, which indicates a rather cheap valuation of RUN.
Based on the Price/Earnings ratio, RUN is valued cheaply inside the industry as 97.85% of the companies are valued more expensively.
RUN's Price/Earnings ratio indicates a rather cheap valuation when compared to the S&P500 average which is at 27.48.
The Forward Price/Earnings Ratio is negative for RUN. No positive earnings are expected for the next year.
Industry RankSector Rank
PE 5.56
Fwd PE N/A
RUN Price Earnings VS Forward Price EarningsRUN Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 10 -10 20 30

4.2 Price Multiples

62.37% of the companies in the same industry are more expensive than RUN, based on the Enterprise Value to EBITDA ratio.
Industry RankSector Rank
P/FCF N/A
EV/EBITDA 113.08
RUN Per share dataRUN EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 5 -5 10 -10 -15

4.3 Compensation for Growth

RUN's earnings are expected to decrease with -39.98% in the coming years. This may justify a cheaper valuation.
PEG (NY)N/A
PEG (5Y)0.13
EPS Next 2Y-64.08%
EPS Next 3Y-39.98%

More info and screens

0

5. Dividend

5.1 Amount

RUN does not give a dividend.
Industry RankSector Rank
Dividend Yield N/A

More info and screens

SUNRUN INC

NASDAQ:RUN (7/17/2025, 8:00:02 PM)

After market: 10.08 +0.12 (+1.2%)

9.96

-0.38 (-3.68%)

Chartmill FA Rating
GICS SectorIndustrials
GICS IndustryGroupCapital Goods
GICS IndustryElectrical Equipment
Earnings (Last)05-07 2025-05-07/amc
Earnings (Next)07-30 2025-07-30/amc
Inst Owners108.99%
Inst Owner Change-0.06%
Ins Owners9.18%
Ins Owner Change3.66%
Market Cap2.28B
Analysts67.41
Price Target11.35 (13.96%)
Short Float %28.73%
Short Ratio2.26
Dividend
Industry RankSector Rank
Dividend Yield N/A
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)2
Avg EPS beat(2)407.56%
Min EPS beat(2)168.55%
Max EPS beat(2)646.57%
EPS beat(4)3
Avg EPS beat(4)231.07%
Min EPS beat(4)-157.51%
Max EPS beat(4)646.57%
EPS beat(8)5
Avg EPS beat(8)-194.18%
EPS beat(12)8
Avg EPS beat(12)-76.31%
EPS beat(16)9
Avg EPS beat(16)-55.76%
Revenue beat(2)1
Avg Revenue beat(2)-0.71%
Min Revenue beat(2)-4.56%
Max Revenue beat(2)3.14%
Revenue beat(4)2
Avg Revenue beat(4)-1.62%
Min Revenue beat(4)-5.73%
Max Revenue beat(4)3.14%
Revenue beat(8)2
Avg Revenue beat(8)-3.07%
Revenue beat(12)6
Avg Revenue beat(12)1.46%
Revenue beat(16)10
Avg Revenue beat(16)3.65%
PT rev (1m)-5.27%
PT rev (3m)-19.38%
EPS NQ rev (1m)0.49%
EPS NQ rev (3m)-16.26%
EPS NY rev (1m)29.96%
EPS NY rev (3m)52.07%
Revenue NQ rev (1m)0.59%
Revenue NQ rev (3m)1.46%
Revenue NY rev (1m)-0.13%
Revenue NY rev (3m)1.94%
Valuation
Industry RankSector Rank
PE 5.56
Fwd PE N/A
P/S 1.09
P/FCF N/A
P/OCF N/A
P/B 0.87
P/tB 0.87
EV/EBITDA 113.08
EPS(TTM)1.79
EY17.97%
EPS(NY)-0.82
Fwd EYN/A
FCF(TTM)-15.51
FCFYN/A
OCF(TTM)-3.18
OCFYN/A
SpS9.12
BVpS11.45
TBVpS11.45
PEG (NY)N/A
PEG (5Y)0.13
Profitability
Industry RankSector Rank
ROA -13.29%
ROE -103.55%
ROCE N/A
ROIC N/A
ROICexc N/A
ROICexgc N/A
OM N/A
PM (TTM) N/A
GM 18.95%
FCFM N/A
ROA(3y)-7.08%
ROA(5y)-4.59%
ROE(3y)-46.51%
ROE(5y)-28.73%
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexcg growth 3YN/A
ROICexcg growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y2.02%
GM growth 5Y-8.23%
F-Score4
Asset Turnover0.1
Health
Industry RankSector Rank
Debt/Equity 5.11
Debt/FCF N/A
Debt/EBITDA 98.7
Cap/Depr 440%
Cap/Sales 135.19%
Interest Coverage N/A
Cash Conversion N/A
Profit Quality N/A
Current Ratio 1.32
Quick Ratio 0.99
Altman-Z -0.17
F-Score4
WACC4.76%
ROIC/WACCN/A
Cap/Depr(3y)457.15%
Cap/Depr(5y)441.02%
Cap/Sales(3y)111.53%
Cap/Sales(5y)108.9%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)126.84%
EPS 3YN/A
EPS 5Y42.86%
EPS Q2Q%150%
EPS Next Y-147.71%
EPS Next 2Y-64.08%
EPS Next 3Y-39.98%
EPS Next 5Y35.19%
Revenue 1Y (TTM)-2.09%
Revenue growth 3Y8.17%
Revenue growth 5Y18.87%
Sales Q2Q%10.06%
Revenue Next Year9.23%
Revenue Next 2Y10.07%
Revenue Next 3Y11.61%
Revenue Next 5Y9.27%
EBIT growth 1Y34.95%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next Year144.84%
EBIT Next 3Y45.33%
EBIT Next 5Y30.2%
FCF growth 1Y-13.38%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y29.51%
OCF growth 3YN/A
OCF growth 5YN/A